|
8V65
Nanorana parkeri saxiphilin:dcGTX2 (co-crystal)
Deposited 2023-12-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
YGU (3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-9-yl hydrogen sulfate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, dcGTX2&3:NpSxph molar ratio 1.2:1
|
Resolution 1.80 Å
R-free 0.218
|
|
8V66
Nanorana parkeri saxiphilin:GTX5 (co-crystal)
Deposited 2023-12-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
YGZ ({[(3aS,4R,7S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, GTX5:NpSxph molar ratio 1.2:1
|
Resolution 1.90 Å
R-free 0.218
|
|
8V67
Nanorana parkeri saxiphilin:C1 (co-crystal)
Deposited 2023-12-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
YH9 ({[(3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-9-(sulfooxy)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, C1&C2:NpSxph molar ratio 1.2:1
|
Resolution 1.90 Å
R-free 0.229
|
|
8V68
Nanorana parkeri saxiphilin:dcSTX (co-crystal)
Deposited 2023-12-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
YGF (3aS,4R,7R,10aS)-2,6-diamino-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H,10H-pyrrolo[1,2-c]purine-10,10-diol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, dcSTX:NpSxph molar ratio 1.2:1
|
Resolution 1.90 Å
R-free 0.225
|
|
8V69
Nanorana parkeri saxiphilin:GTX2 (co-crystal)
Deposited 2023-12-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
YGQ Gonyautoxin II × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, GTX2&3:NpSxph molar ratio 1.2:1
|
Resolution 1.95 Å
R-free 0.212
|
|
9Y91
Nanorana parkeri saxiphilin:STX-C13-NBz (co-crystal)
Deposited 2025-09-12
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–854(854 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 1
A1CTW N-{[(2Z,3aS,4S,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl}benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277.15 K;20-25% v/v PEG400, 4-5% w/v PGA-LM, 100-200 mM sodium acetate, pH 5.0, STX-C13-NBz:NpSxph molar ratio 1.2:1
|
Resolution 1.95 Å
R-free 0.223
|